VRCA
NASDAQ · Pharmaceuticals
Verrica Pharmaceuticals Inc
$5.65
+0.01 (+0.18%)
Open$5.46
Previous Close$5.64
Day High$5.92
Day Low$5.30
52W High$9.82
52W Low$3.28
Volume—
Avg Volume38.5K
Market Cap96.72M
P/E Ratio—
EPS$-1.03
SectorPharmaceuticals
Analyst Ratings
Strong Buy
12 analysts
Price Target
+69.7% upside
Current
$5.65
$5.65
Target
$9.59
$9.59
$7.88
$9.59 avg
$13.36
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 55.03M | 34.84M | 35.73M |
| Net Income | -27,665,532 | -15,764,833 | 6.74M |
| Profit Margin | -50.3% | -47.8% | 18.9% |
| EBITDA | -20,468,638 | -12,311,767 | 12.85M |
| Free Cash Flow | — | — | 8.80M |
| Rev Growth | +57.9% | +57.9% | +7.9% |
| Debt/Equity | 0.04 | 0.04 | 0.56 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |